Prodige: A phase 3 randomized placebo-controlled trial of thromboprophylaxis using dalteparin low-molecular-weight heparin (LMWH) in patients with newly diagnosed malignant glioma Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Perry, J
  • Rogers, L
  • Laperriere, N
  • Julian, James
  • Geerts, W
  • Agnelli, G
  • Malkin, M
  • Sawaya, R
  • Baker, R
  • Finch, T
  • Levine, M

publication date

  • July 1, 2005